1. Wharam JF, Landon BE, Galbraith AA, et al. Emergency department use and subsequent hospitalizations among members of a high-deductible health plan. JAMA 2007;297(10):1093-102.
2. Kaiser Family Foundation. Prescription drug trends fact sheet; June 2006 Update. Available at: http://www.kff.org/rxdrugs/3057.cfm. Accessed April 30, 2007.
3. Personal communication with Mark Cauthen, Risk Supervisor, City of Colorado Springs; June 11, 2007.
4. Jin GZ, Sorensen AT. Information and consumer choice: the value of publicized health plan ratings. J Health Econ 2006;25(2):248-75
5. Mukamel DB, Weimer DL, Zwanziger J, et
al Quality report cards, selection of cardiac surgeons, and racial disparities:
a study of the publication of the New York State cardiac surgery reports.
6. Beaulieu ND. Quality information and consumer
health plan choices. J Health Econ 2002;21(1):43-63.
7. Scanlon DP, Chernew ME, McLaughlin, Solon
G. The impact of health plan report cards on managed care enrollment. J
Health Econ 2002;21(1):19-41.
8. Wedig GJ, Tai-Seale M. The effect of report
cards on consumer choice in the health insurance market, J
Health Econ 2002;21(6):1031-48.
9. Chernew M, Scanlon DP. Health plan report
cards and insurance choice. Inquiry 1998;35(1):9-22.
10. Dafny L, Dranove D. Do report
cards tell people anything they don't already know? The case of Medicare
HMOs. NBER Working Paper 2004;1142
11. Chernew ME, Gowrisankaran G, Scanlon
DP. Learning and the value of information: evidence from health plan report
cards. NBER Working Paper 2001 Nov;8589.
12. Dranove D, Kessler D, McClellan M,
Satterthwaite M. Is more information better? The effects of “report
cards” on health care providers. J Political Econ 2003;111:555-88.
13. Arora R, Singer J, Arora A. Influence
of key variables on the patients' choice of a physician. Qual
Manag Health Care 2004;13(3):166-73.
14. Cutler DM, Huckman RS, Landrum MB. The
role of information in medical markets: an analysis of publicly reported
outcomes in cardiac surgery. Am Econ Rev 2004;94(2):342-6.
15. McNamara P. Provider-specific report
cards: a tool for health sector accountability in developing countries. Health
Policy Plan 2006;21(2):101-9.
16. Hibbard JH, Peters E. Supporting informed
consumer health care decisions: data presentation approaches that facilitate
the use of information in choice. Annu Rev Public Health 2003;24:413-33.
17. Hibbard JH, Stockard J, Tusler M. Hospital
performance reports: impact on quality, market share, and reputation. Health
18 Newhouse JP. Consumer-directed
health plans and the RAND Health Insurance Experiment. Health
19. Keeler EB, Brook RH, Goldberg
GA, et al. How free care reduced hypertension in the health insurance experiment.
20. Brook RH, Ware JE Jr, Rogers
WH, et al. Does free care improve adults' health? Results from a randomized
controlled trial. N Engl J Med 1983;309(23):1426-34.
21. Bozic KJ, Smith AR, Hariri
S, et al. The 2007 ABJS Marshall Urist Award: The impact of direct-to-consumer
advertising in orthopaedics. Clin Orthop Relat Res 2007;458:202-19.
22. Dumbleton JH, Manley MT.
Metal-on-metal total hip replacement: what does the literature say? J
23. Learmonth ID. Total hip replacement
and the law of diminishing returns. J Bone Joint Surg
24. Bozic KJ, Morshed S, Silverstein
MD, et al. Use of cost-effectiveness analysis to evaluate new technologies
in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J
Bone Joint Surg Am 2006;88(4):706-14.
25. Mendenhall S. Hip and knee
implant review. Orthop Net News 2007 Jan;1-16.
26. Rowe J, Robinson JC. Consumer-directed
health insurance: the next generation. Interview by James C. Robinson. Health
Aff 2005;Supplement Web Exclusives:W5-583-90.
27. Kane RL, Johnson PE, Town
RJ, Butler M. Economic incentives for preventive care. Rockville, MD: Agency
for Healthcare Research and Quality; August 2004. Evidence Report/Technology
Assessment 101. AHRQ Publication No. 04-0024-2.
28. Cranor CW, Bunting BA, Christensen
DB. The Asheville Project: long-term clinical and economic outcomes of a
community pharmacy diabetes care program. J Am Pharm Assoc 2003;43(2):173-84.
29. Hey K, Perera R. Competitions
and incentives for smoking cessation. Cochrane Database
Syst Rev 2005;2:CD004307.
30. Guiffrida A, Torgerson D.
Should we pay the patient? Review of financial incentives to enhance patient
compliance. Br Med J 1997;20:703-5.
31. Klesges RC, Glasgow RE, Klesges
LM, et al. Competition and relapse prevention training in worksite smoking
modification. Health Educ Res 1987;2(1):5-14.
32. Koffman DM, Lee JW, Hopp JW,
Emont SL. The impact of including incentives and competition in a workplace
smoking cessation program on quit rates. Am J Health Prom 1998;13(2):105-11.
33. Windsor RA, Lowe JB, Bartlett,
EE. The effectiveness of a worksite self-help smoking cessation program:
a randomized trial. J Behav Med 1988;11(4):407-21.
34. Donatelle RJ, Prow SL, Champeau
D, Hudson D. Randomised controlled trial using social support and financial
incentives for high risk pregnant smokers: Significant Other Support (SOS)
program. Tob Control 2000;9(Suppl III):iii67-iii69.
35. Emont SL, Cummings KM. Using
a low-cost, prize-drawing incentive to improve a recruitment rate at a work-site
smoking cessation clinic. J Occup Med 1992;34(8):771-4.
36. Gottlieb NH, Nelson A. A systematic
effort to reduce smoking at the workplace. Health Educ Q 1990;17(1):99-118.
37. Jeffery RW, Forster JL, French
SA, et al. The Healthy Worker Project: a work-site intervention for weight
control and smoking cessation. Am J Pub Health 1993;83(3):395-402.
38. Stitzer ML, Bigelow GE. Contingent
payment for carbon monoxide reduction: effects of pay amount. Behav
39. Follick MJ, Fowler JL, Brown
RA. Attrition in worksite weight-loss interventions: the effects of an incentive
procedure. J Consult Clin Psychol 1984;52(1):139-40.
40. Wing RR, Jeffery RW, Pronk
N, Hellerstedt WL. Effects of a personal trainer and financial incentives
on exercise adherence in overweight women in a behavioral weight loss program. Obes
41. Dey P, Foy R, Woodman M, Fullard
B, Gibbs A. Should smoking cessation cost a packet? A pilot randomized controlled
trial of the cost-effectiveness of distributing nicotine therapy free of
charge. Br J Gen Pract 1999;49(439):127-8
42. Hughes JR, Wadland WC, Fenwick
JW, et al. Effect of cost on the self-administration and efficacy of nicotine
gum: a preliminary study. Prev Med 1991;20(4):486-96.
43. Jeffery RW, Forster JL, Baxter
JE, et al. An empirical evaluation of the effectiveness of tangible incentives
in increasing participation and behavior change in a worksite health promotion
program. Am J H Promot 1993;8(2):98-100.
44. Fisher E, Wennberg D, Stukel
T, et al. The implications of regional variations in medicare spending.
Part 2: Health outcomes and satisfaction with care. Ann Intern Med
45. Promoting consumerism through
responsible health care benefit design. Washington, DC: National Business
Coalition on Health; 2006.
46. UnitedHealth premium designation
program; summary of methodology. Minnetonka, MN; 2007.
47. Robinow, A. Consumer incentives;
strong examples in action: patient choice health care. Presented at the
National Business Coalition on Health/Leapfrog Group/Bridges to Excellence
meeting, advancing Value-Driven Health Care: The Third Annual Incentives
and Rewards Symposium. Philadelphia, PA: Buyers Health Care Action Group;
2007 May 15.
48. Briesacher B, Kamal-Bahl,
Hochberg M, Orwig D, Kahler KH. Three-tiered-copayment drug coverage and
use of noonsterodial anti-inflammatory drugs. Arch Int
Med. 2004; 164:1679-84.
49. Huskamp HA, Deverka PA, Epstein
AM, et al. The effect of incentive-based formularies on prescription-drug
utilization and spending. N Engl J Med 2003;349(23):2224-32.
50. Huskamp HA, Dverka PA, Epstein
AM, et al. Impact of 3-tier formularies on drug treatment of
attention-deficit/hyperactivity disorder in children. Arch Gen
51. Joyce GF, Escarce JJ, Solomon
MD, Goldman DP. Employer drug benefit plans and spending on prescription
drugs. JAMA 2002:288(14):1733-9.
52. Kamal-Bahl S, Briesacher B.
How do incentive-based formularies influence drug selection and spending
for hypertension. Health Aff 2004:23(1):227-36.
53. Schneeweiss S, Walker AM,
Glynn RJ, et al. Outcomes of reference pricing for angiotensin-converting-enzyme
inhibitors. N Engl J Med 2002:346(11):822-9.
54. Schneeweiss S, Soumerai SB,
Maclure M, et al. Clinical and economic consequences of reference pricing
for dihydropyridine calcium channel blockers. Clin Pharmacol
55. Adams AS, Soumerai SB, Ross-Degnan
D. Use of antihypertensive drugs by Medicare enrollees: does type of drug
coverage matter? Health Aff 2001;20(1):276-86.
56. Goldman DP, Joyce GF, Escarce
JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill.
57. Piette JD, Heisler M, Wagner
TH. Cost-related medication underuse among chronically ill adults: the
treatments people forgo, how often, and who is at risk. Am J Pub
58. Tseng C, Brook RH, Keeler
E, et al. Cost-lowering strategies used by Medicare beneficiaries who exceed
drug benefit caps and have a gap in drug coverage. JAMA 2004;292:952-60.
59. Federman AD, Adams AS, Ross-Degnan
D, et al. Supplemental insurance and use of effective cardiovascular drugs
among elderly Medicare beneficiaries with coronary heart disease.
60. Gibson TB, Mark TL, McGuigan
KA, et al. The effects of prescription drug copayments on statin adherence.
Am J Manag Care 2006;12:509-17.
61. Dormuth CR, Glynn RJ, Neumann
P, et al. Impact of two sequential drug cost-sharing policies on the use
of inhaled medications in older patients with chronic obstructive pulmonary
disease or asthma. Clin Ther 2006;28:964-78.
62. Piette JD, Heisler M, Wagner
TH. Problems paying out-of-pocket medication costs among older adults with
diabetes. Diabetes Care 2004;27:384-91.
63. Piette JD, Wagner TH, Potter
MB, Schillinger D. Health insurance status, cost-related medication underuse,
and outcomes among diabetes patients in three systems of care. Med
64. Gibson TB, Ozminkowski RJ,
Goetzel RZ. The effects of prescription drug cost sharing: a review of the
evidence. Am J Manag Care 2005;11(11):730-40.
65. Mojtabai R, Olfson M. Medication
costs, adherence and health outcomes among Medicare beneficiaries. Health
66. Tamblyn R, Laprise R, Hanley
JA, et al. Adverse events associated with prescription drug cost-sharing
among poor and elderly persons. JAMA 2001;285(4):421-9.
67. Heisler M, Langa KM, Eby EL,
et al. The health effects of restricting prescription medication use because
of cost. Med Care 2004;42(7):623-5.
68. Dudley, RA, Rosenthal, MB. Pay
for performance: a decision guide for purchasers. Rockville, MD: Agency for
Healthcare Research and Quality; 2006. AHRQ Publication No. 06-0047. Available at:
Accessed October 3, 2007.
69. Rosenthal MB, Dudley RA.
Pay-for-performance: will the latest payment trend improve care?
70. McGlynn EA. Identifying,
Categorizing, and evaluating healthcare efficiency measures. Prepared for
the Agency for Healthcare Research and Quality, Rockville, MD, under Contract
282-00-0005, Task Order 21; 2007.
71. Kennedy J, Coyne J, Sclar
D. Drug affordability and prescription noncompliance in the United States:
1997-2002. Clin Ther 2004;26(4):607-14.
72. Safran DG, Neuman P, Schoen
C, et al. Prescription drug coverage and seniors: findings from a 2003 national
survey. Health Aff 2005;Web exclusive W5:152-66.
73. Soumerai SB, Pierre-Jacques
M, Zhang F, et al. Cost-related medication nonadherence among elderly and
disabled Medicare beneficiaries : a national survey 1 year before the Medicare
drug benefit. Arch Intern Med 2006;166(17):1829-35.
74. Wilson IB, Rogers WH, Chang
H, Safran DG. Cost-related skipping of medications and other treatments
among Medicare beneficiaries between 1998 and 2000. Results of a national
study. J Gen Intern Med 2005;20(80):715-20.
75. Mojtabai R, Olfson M. Medication
costs, adherence and health outcomes among Medicare beneficiaries. Health
76. Kennedy J, Morgan S. A cross-national
study of prescription non-adherence due to cost: data from the joint Canada-United
States survey of health. Clin Ther 2006;28:1217-24.
77. Piette JD, Heisler M. The
relationship between older adults' knowledge of their drug coverage and
medication cost problems. J Am Geriatr Soc 2005;54:91-6.
78. Bann CM, Berkman N, Kuo TM.
Insurance knowledge and decision-making practices among Medicare beneficiaries
and their caregivers. Med Care 2004;42:1091-9.
79. McCall N, Rice T, Sangl J.
Consumer knowledge of Medicare and supplemental health insurance benefits.
Health Serv Res 1986:20:633-57.
80. McCormack LA, Uhrig JD. How
does beneficiary knowledge of the Medicare program vary by type of insurance.
Med Care 2003;41:972-8.
81. Garnick DW, Hendricks AM,
Thorpe KE, et al. How well do Americans understand their health coverage? Health
82. Marquis MS. Consumers' knowledge
about their health insurance coverage. Health Care Financ Rev
83. Hibbard JH, Jewett JJ, Engelmann
S, Tusler M. Can Medicare beneficiaries make informed choices? Health
84. Uhrig JD, Bann CM, McCormack
LA, Rudolph N. Beneficiary knowledge of original Medicare and Medicare managed
care. Med Care 2006;44(11) :1020-9 .
85. Meredith LS, Humphrey N, Orlando
M, Camp P. Knowledge of health care benefits among patients with depression. Med
86. Shrank WH, Fox SA, Kirk A,
et al. The effect of pharmacy benefit design on patient-physician communication
about cost. J Gen Intern Med 2006;21:334-9.
87. Alexander GC, Casalino LP,
Tseng C, et al. Barriers to patient physician communication about out-of-pocket
costs. J Gen Intern Med 2004;19:856-60.
88. Sofaer S, Kreling B, Kenney
E, et al. Family members and friends who help beneficiaries make health
decisions. Health Care Financ Rev 2001:23:105-21.
89. Cihak J. When you're 64; what
consumers don't know about Medicare. Issue Brief. Oakland, CA: California
Health Care Foundation; 2006. Available at:
Accessed October 3, 2007.
90. Public opinion on Medicare
Part D - the Medicare prescription drug benefit. Kaiser Public Opinion Spotlight.
Washington, DC: Kaiser Family Foundation; 2006. Available at:
Accessed October 3, 2007.
91. O'Connor AM, Legare F, Stacey,
D. Risk communication in practice: the contribution of decision aids. Br
Med J 2003;327(7417):736-40.
92. Hibbard, JH, Peters, E. Supporting
informed consumer health care decisions: data presentation approaches that
facilitate the use of information in choice. Annu Rev Pub Health
93. Fraenkel L, McGraw, S. What
are the essential elements to enable patient participation in medical decision
making? J Gen Intern Med 2007;22(5):614-9.
94. DeMonaco HJ, von Hippel E.
Reducing medical costs and improving quality via self-management tools.
PLoS Med 4(4): e104; Available at
Accessed October 3, 2007.
95. Kahneman D, Tversky A. Prospect
theory: an analysis of decision under risk. Econometrica 1979;XLVII:263-91.
96. Personal communication with
Elizabeth H. McNamee, St. Luke's Health Initiatives, Phoenix, AZ;
May 9, 2007.
97. Navigator™ by Tufts
Health Plan Benefit Summary. Watertown, MA: Commonwealth of Massachusetts,
Group Insurance Commission; 2007 March. Available at: http://www.tuftshealthplan.com/pdf/GIC%20Benefit%20Summary_0307_final.pdf.
Accessed on October 11, 2007.
98. Hibbard JH, Stockard J, Tusler
M. Does publicizing hospital performance stimulate quality improvement efforts?
Health Aff 2003;22(2):84-94.
99. Mehrotra A, Grier SA, Dudley
RA. The relationship between health plan advertising and market incentives:
evidence of risk selective behavior. Health Aff 2006;25(3):759-65.
100. Dudley RA, Frolich A,
Robinowitz DL, et al. Strategies to support quality-based purchasing: a
review of the evidence. Rockville, MD: Agency for Healthcare Research and
Quality; 2004. Technical Review 10. AHRQ Publication No. 04-0057.
101. de Brantes F. Best practices
and lessons learned in provider rewards: evidence to date. Presented at
the National Business Coalition on Health/Leapfrog Group Bridges to Excellence
meeting, Advancing Value-Driven Healthcare. Philadelphia, PA; 2007 May 15.
102. Shaller D, Sofaer S, Findlay
SD, et al. Consumers and quality-driven health care: a call to action. Health
103. Robinson JC. Theory and
practice in the design of physician payment incentives. Milbank Q
104. Sofaer S, Firminger K.
Patient perceptions of the quality of health services. Annu Rev Pub
105. Hibbard JH, Sofaer S, Jewett
JJ. Condition-specific performance information: assessing salience, comprehension,
and approaches for communicating quality. Health Care Financ Rev
106. Barry MJ, Fowler FJ Jr,
Mulley AG Jr, et al. Patient reactions to a program designed to facilitate
patient participation in treatment decisions for benign prostatic hyperplasia. Med
107. Iglehart JK. Changing health
insurance trends. New Engl J Med 2002; 347:956-62.
108. Herzlinger RE. Let's put
consumers in charge of health care. Harvard Bus Rev 2002;80(7):44-55.
109. Zucker D, Hopkins RS, Sly,
DF, et al. Florida's "truth” campaign: a counter-marketing,
anti-tobacco media campaign 2000: J Pub Health Manage
110. Williams AF, Wells JK,
Reinfurt DW. Increasing seat belt use in North Carolina. In: Hornik RC,
ed. Public health communication: evidence for behavior change. Mahwah, NJ:
Lawrence Erlbaum; 2002. p. 85-96.
111. Hanson DJ. Social norms
marketing is highly effective. Alcohol Problems and Solutions. Potsdam,
NY: National Social Norms Research Center; 2003. Available at:
Accessed October 3 2007.
112. Nielsen-Bohlman L, Panzer
AM, Kindig DA, eds. Health literacy: a prescription to end the confusion.
Washington, DC: National Academies Press; 2004.
113. Harmon-Jones E, Mills J,
eds. Cognitive dissonance: progress on a pivotal theory in social psychology.
Washington, DC: American Psychological Association; 1999.
114. Gladwell M. The tipping
point: how little things can make a big difference. New York: Little Brown;
115. Strombom BA, Buchmueller
TC, Feldstein PJ. Switching costs, price sensitivity and health plan choice.
J Health Econ 2002;21(1):89-116.
116. Hibbard JH, Mahoney E,
Stock R, Tusler M. Does increasing patient activation result in improved
self-management behaviors? A further validation of the Patient Activation
Measure (PAM). Health Serv Res 2005;40(6 Pt 1):1918-30.
117. Greene J, Hibbard J, Tusler
M. How much do health literacy and patient activation contribute to older
adults' ability to manage their health? Washington, DC: AARP Public
Policy Institute; June 2005. PPI Publication 2005-05. Available at:
Accessed October 3, 2007.
118. Levinson W, Kao A, Kuby
A, Thisted RA. Not all patients want to participate in decision making:
a national study of public preferences. J Gen Intern Med 2005;20:531-5.
119. Dohan D, Schrag D. Using
navigators to improve care of underserved patients. Cancer 2005;104(4):848-55.
120. Clanton M, Freeman H. Patient
navigator program reduces cancer health disparities. NCI Cancer Bulletin 2004 Aug 17;1(33):1-2. Available at: http://www.cancer.gov/ncicancerbulletin/NCI_Cancer_Bulletin_081704/page3.
Accessed October 7, 2007.
121. Burack JH, Impellizzeri
P, Homel P, Cunningham JN Jr. Public reporting of surgical mortality: a
survey of New York State cardiothoracic surgeons. Ann Thorac Surg
122. Werner RM, Asch DA. The
unintended consequences of publicly reporting quality information. JAMA
Return to Contents
Current as of November 2007
AHRQ Publication No. 07(08)-0059
Final Contract Report. Consumer Financial Incentives: A Decision
Guide for Purchasers. AHRQ Publication No. 07(08)-0059. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/qual/value/incentives.htm